When considering all the info in this thread, I see similarities between Long-COVID and ME/CFS, but also places where they differ and my read is that persistent micro-clots may be a difference. I base this on the reported finding that Long-COVID patents have low SvO2, presumably due to microclots. In contrast, ME/CFS patients have normal SvO2 at rest and HIGH SvO2 during exercise (see earlier studies posted).
So in one condition, we have the inability to extract oxygen (ME/CFS) and in the other we have hyper-extraction of oxygen due to poor tissue perfusion secondary to micro-clots (Long-COVID). Based on these findings, how can the same pathology be occurring?
In addition, the SARS-COV-2 is very tightly linked with severe clotting pathology while viruses like EBV, HHV-6 and Enteroviruses are not known to cause this type of severe clotting with active infection.
The low ESR found in ME/CFS also points away from clotting as the primary pathology as you would typically find a high ESR in hypercoagulation syndromes.
I think it is more likely the in ME/CFS we are seeing some hypercoagulation due to inflammation and autoantibodies associated with a variation of anti-phospholipid syndrome. However, if it were clotting alone causing the issue, I think we would see a low SvO2, and we don't.
This makes me think we are also seeing dysautonomia impacting the capillary blood flow (as described in the paper posted by
@Pyrrhus earlier), mitochondrial dysfunction (causing inability to utilize oxygen), and possibly poor release of O2 from RBC due to their altered deformability. All of these factors would be consistent with the high SvO2 (low oxygen extraction) which has been observed.
This isn't to say that HELP Apheresis wouldn't be useful, perhaps even greatly so, but in my opinion, it would be for other reasons than the type of micro-clot occurring in Long-COVID.